CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.73%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.04B
AUM Growth
+$7.04B
(+6.8%)
Cap. Flow
+$73.9M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
55
Reduced
52
Closed
9
Top Buys
| 1 |
Citigroup
C
|
$55.6M |
| 2 |
Visa
V
|
$20.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$12.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$11.6M |
Top Sells
| 1 |
Home Depot
HD
|
$40.1M |
| 2 |
Nike
NKE
|
$11.2M |
| 3 |
Mondelez International
MDLZ
|
$11.1M |
| 4 |
Centene
CNC
|
$10.6M |
| 5 |
Colgate-Palmolive
CL
|
$10.6M |
Sector Composition
| 1 | Financials | 27.87% |
| 2 | Healthcare | 18.82% |
| 3 | Consumer Discretionary | 16.92% |
| 4 | Communication Services | 15.48% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Jazz Pharmaceuticals
JAZZ
$7.96B
| $7.31M | 0.1% |
49,951
-55,097
| -52% | -$8.06M |
|
|
ESRX
52
DELISTED
Express Scripts Holding Company
ESRX
| $7.24M | 0.1% |
114,268
+51,405
| +82% | +$3.25M |
|
53
Exact Sciences
EXAS
$9.25B
| $7.22M | 0.1% |
153,130
-9,580
| -6% | -$451K |
|
54
Zimmer Biomet
ZBH
$20.6B
| $6.98M | 0.1% |
+59,639
| New | +$6.98M |
|
55
Exelixis
EXEL
$10B
| $6.9M | 0.1% |
284,588
-10,587
| -4% | -$257K |
|
|
PTLA
56
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.64M | 0.09% |
122,801
+26,211
| +27% | +$1.42M |
|
57
Viatris
VTRS
$12.3B
| $5.85M | 0.08% |
186,539
-8,100
| -4% | -$254K |
|
58
Vertex Pharmaceuticals
VRTX
$102B
| $5.8M | 0.08% |
38,146
+32,146
| +536% | +$4.89M |
|
59
Teva Pharmaceuticals
TEVA
$21.4B
| $5.74M | 0.08% |
326,269
+76,038
| +30% | +$1.34M |
|
|
AIMT
60
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $5.72M | 0.08% |
230,900
-17,900
| -7% | -$444K |
|
61
Insulet
PODD
$24.1B
| $5.57M | 0.08% |
101,083
-5,982
| -6% | -$330K |
|
62
Sarepta Therapeutics
SRPT
$1.94B
| $5.56M | 0.08% |
122,469
+941
| +0.8% | +$42.7K |
|
|
NUVA
63
DELISTED
NuVasive, Inc.
NUVA
| $5.26M | 0.07% |
+94,827
| New | +$5.26M |
|
|
HZNP
64
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.86M | 0.07% |
383,148
-5,136
| -1% | -$65.1K |
|
|
ONCE
65
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.67M | 0.07% |
52,349
+68
| +0.1% | +$6.06K |
|
66
NovoCure
NVCR
$1.34B
| $4.58M | 0.07% |
230,500
-43,100
| -16% | -$855K |
|
67
Cardinal Health
CAH
$35.8B
| $4.57M | 0.07% |
68,307
-3,075
| -4% | -$206K |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $4.57M | 0.07% |
146,726
-1,272
| -0.9% | -$39.6K |
|
|
AERI
69
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.34M | 0.06% |
89,384
-165
| -0.2% | -$8.02K |
|
|
KTWO
70
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.27M | 0.06% |
201,192
+17,615
| +10% | +$374K |
|
71
Ultragenyx Pharmaceutical
RARE
$3.07B
| $4.14M | 0.06% |
77,691
+764
| +1% | +$40.7K |
|
|
DERM
72
DELISTED
Dermira, Inc.
DERM
| $4.13M | 0.06% |
153,061
+32,246
| +27% | +$871K |
|
|
TVRD
73
Tvardi Therapeutics, Inc. Common Stock
TVRD
$272M
| $3.99M | 0.06% |
291,341
+126,330
| +77% | +$1.73M |
|
|
ITCI
74
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.82M | 0.05% |
242,156
+24,194
| +11% | +$382K |
|
|
EGRX
75
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.82M | 0.05% |
64,042
+15,301
| +31% | +$912K |
|